Evans C, Lotz J, Bhandari M, Hellier R, Wang X, Lott R
J Clin Lab Anal. 2022; 36(9):e24595.
PMID: 35837992
PMC: 9459248.
DOI: 10.1002/jcla.24595.
Khamisi S, Lundqvist M, Emadi P, Almby K, Ljunggren O, Karlsson F
J Endocrinol Invest. 2021; 44(9):1905-1911.
PMID: 33515213
PMC: 8357771.
DOI: 10.1007/s40618-021-01505-8.
Pacini F, Pinchera A, Giani C, Grasso L, Doveri F, BASCHIERI L
J Endocrinol Invest. 1980; 3(3):283-92.
PMID: 7430557
DOI: 10.1007/BF03348277.
Van Herle A, Van Heuverswyn B, Dumont J
J Endocrinol Invest. 1981; 4(1):107-20.
PMID: 7240667
DOI: 10.1007/BF03349426.
Wilkin T, BECK J, Gunn A, Potts R, Young R
J Endocrinol Invest. 1980; 3(4):389-93.
PMID: 7204886
DOI: 10.1007/BF03349376.
Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter.
Feldt-Rasmussen U, PETERSEN P, Date J, Madsen C
J Endocrinol Invest. 1982; 5(3):161-4.
PMID: 7108151
DOI: 10.1007/BF03349472.
Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.
Marcocci C, Chiovato L, Mariotti S, Pinchera A
J Endocrinol Invest. 1982; 5(1):13-9.
PMID: 6896520
DOI: 10.1007/BF03350476.
Serum thyroglobulin in newborns' cord blood, in childhood and adolescence: a physiological indicator of thyroidal status.
Pacini F, Lari R, La Ricca P, Grasso L, Taddei D, Bardini N
J Endocrinol Invest. 1984; 7(5):467-71.
PMID: 6512182
DOI: 10.1007/BF03348452.
Clinical pharmacokinetics of antithyroid drugs.
Kampmann J, Hansen J
Clin Pharmacokinet. 1981; 6(6):401-28.
PMID: 6172233
DOI: 10.2165/00003088-198106060-00001.
Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy.
de Bruin T, Patwardhan N, Brown R, Braverman L
Clin Exp Immunol. 1988; 72(3):481-5.
PMID: 3168323
PMC: 1541569.
Immunoreactive thyroglobulin in sera and saliva of patients with various thyroid disorders: role of autoantibodies.
Van Herle A, Rosenblit P, Van Herle T, Van Herle P, GREIPEL M, Kellett K
J Endocrinol Invest. 1989; 12(3):177-82.
PMID: 2723340
DOI: 10.1007/BF03349955.
Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.
Talbot J, Duron F, FERON R, Aubert P, Milhaud G
J Endocrinol Invest. 1989; 12(9):589-95.
PMID: 2573625
DOI: 10.1007/BF03350008.
[Early changes in thyroid hormones following radioiodine therapy of hyperthyroidism with reference to etiology and accompanying medication].
Kreisig T, Abenhardt W, Mann K, Kirsch C, Moser E
Klin Wochenschr. 1989; 67(7):386-92.
PMID: 2473242
DOI: 10.1007/BF01711266.
Effect of therapy on the serum thyroglobulin concentration in patients with toxic diffuse goiter, toxic nodular goiter and toxic adenoma.
Ericsson U, Tegler L, DYMLING J, Thorell J
J Endocrinol Invest. 1987; 10(4):351-7.
PMID: 2445808
DOI: 10.1007/BF03348146.
Thyroid iodine content and serum thyroglobulin level following external irradiation to the neck for Hodgkin's disease.
Schlumberger M, Sebagh M, De Vathaire F, Bayle C, Fragu P, Parmentier C
J Endocrinol Invest. 1990; 13(3):197-203.
PMID: 2365955
DOI: 10.1007/BF03349539.
Lymphocyte blastogenic response to human thyroglobulin in Graves' disease, Hashimoto's thyroiditis, and metastatic thyroid cancer.
Aoki N, Degroot J
Clin Exp Immunol. 1979; 38(3):523-30.
PMID: 583403
PMC: 1537909.
Interference of thyroglobulin in TSab detection by radio-receptor assay.
Fenzi G, Bartalena L, Macchia E, Monzani F, Checchi M
J Endocrinol Invest. 1979; 2(2):221-2.
PMID: 582828
DOI: 10.1007/BF03349318.
